Page 106 | Certara

Case Study

Providing Around-the-Clock Regulatory Support While Enhancing Team Chemistry

Advaxis Inc. is devoted to the discovery, development, and commercialization of immunotherapies based on a…

CertaraJune 3, 2022

Case Study

PBPK Modeling in Adults Enables DDI Risk Assessment in Children with SMA

In 2020, the US FDA approved Risdiplam (Evrysdi®) as the first orally administered drug to…

CertaraJune 2, 2022

On-Demand Webinar

eCTD Submission Challenges

Industry standards are continually evolving, creating an environment of rapid change. With change comes challenges.…

CertaraJune 1, 2022

Case Study

Leveraging Clinical Data from One Rare Disease to Support Drug Approval for Another

Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare genetic disease that causes abnormal blood clot…

CertaraJune 1, 2022

Case Study

PK Modeling Supports Dosing Strategy for Patients with Hepatic Impairment

Primary biliary cholangitis (PBC) is a chronic disease that impedes bile flow from the liver,…

CertaraMay 31, 2022

On-Demand Webinar

Learn how to shorten the drug discovery design-make-test-analyze cycle with D360

Researchers use D360 to query research data efficiently across different data sources and to create…

CertaraMay 25, 2022

Blog

The Utility of Model-Informed Drug Development for Rare Diseases

Model-informed drug development (MIDD) is a network of closely integrated ecosystems that can seamlessly position…

CertaraMay 20, 2022

Announcement

Certara Earns 2022 Great Place to Work Certification™

Princeton, NJ, May 17, 2022. Certara, Inc., a global leader in biosimulation, today announced that…

CertaraMay 17, 2022

Fact Sheet

CoAuthor Factsheet

Discover the key features and benefits of CoAuthor in this detailed fact sheet.

CertaraMay 16, 2022

On-Demand Webinar

Ask Me Anything: Career Opportunities in Regulatory & Medical Writing

Have you ever wondered what it would be like to be a Regulatory or Medical…

CertaraMay 12, 2022

Providing Around-the-Clock Regulatory Support While Enhancing Team Chemistry

PBPK Modeling in Adults Enables DDI Risk Assessment in Children with SMA

eCTD Submission Challenges

Leveraging Clinical Data from One Rare Disease to Support Drug Approval for Another

PK Modeling Supports Dosing Strategy for Patients with Hepatic Impairment

Learn how to shorten the drug discovery design-make-test-analyze cycle with D360

The Utility of Model-Informed Drug Development for Rare Diseases

Certara Earns 2022 Great Place to Work Certification™

CoAuthor Factsheet

Ask Me Anything: Career Opportunities in Regulatory & Medical Writing

Newsletter sign up

Quick links

Solutions

Contact